ARGENS SE SP.ADR/1 -,10 revenue breakdown overview

ARGENS SE SP.ADR/1 -,10 revenue for the last year amounted to 1.15 B EUR, the most of which — 1.11 B EUR — came from its highest performing source at the moment, Antibody-based Medicines, the year earlier bringing 383.79 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought ARGENS SE SP.ADR/1 -,10 975.40 M EUR, and the year before that — 352.87 M EUR.